This data is invaluable for your healthcare provider in determining whether dose adjustments are needed and whether your headaches are trending in the right direction
Aroda VR, Rosenstock J, Wysham C et al (2016) Efficacy and safety of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and metformin: the LixiLan-L randomized trial
Kadonosono, T., Yamano, A., Goto, T., Tsubaki, T., Niibori, M., Kuchimaru, T., et al., J
ghrelinELISA kit Demeditec Diagnostic GmbH, Germany (sensitivity 25 pg/ml)
Amjad Askary, Noriko Shimazaki, Niki Bayat, Michael R Lieber, "Modeling of the RAG reaction mechanism", Cell reports, 7 (2): 307-315 (2014) [link]